Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism-Reference-Cited by-同舟云学术

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism

Published:2021-03-26 Issue:5 Volume:19 Page:1259-1270
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Röshammar Daniel¹,Huang Fenglei²,Albisetti Manuela³,Bomgaars Lisa⁴,Chalmers Elizabeth⁵,Luciani Matteo⁶,Halton Jacqueline⁷,Mitchell Lesley G.⁸,Bergstrand Martin¹,Ibrahim Moustafa M. A.¹⁹,Joseph David²,Tartakovsky Igor¹⁰,Gropper Savion¹¹,Brueckmann Martina¹⁰¹²,Brandão Leonardo R.¹³¹⁴^ORCID

Affiliation:

1. Pharmetheus AB Uppsala Sweden

2. Translational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USA

3. Hematology Department University Children’s Hospital Zürich Switzerland

4. Department of Pediatrics Texas Children’s Cancer CenterBaylor College of Medicine Houston Texas USA

5. Department of Haematology Royal Hospital for Children, Glasgow Scotland United Kingdom

6. Pediatric Hematology/Oncology Department Pediatric Hospital Bambino Gesù Rome Italy

7. Department of Pediatrics, Children’s Hospital of Eastern Ontario University of Ottawa Ottawa Ontario Canada

8. Katz Group Centre for Research University of Alberta Edmonton Alberta Canada

9. Department of Pharmacy Practice Helwan University Cairo Egypt

10. Therapeutic Area Cardiovascular Medicine Boehringer Ingelheim International GmbH Ingelheim Germany

11. Therapeutic Area Inflammation Medicine Boehringer Ingelheim International GmbH Ingelheim Germany

12. Faculty of Medicine Mannheim of the University of Heidelberg Mannheim Germany

13. Department of Paediatrics The Hospital for Sick Children University of Toronto Toronto Ontario Canada

14. Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15277

Reference30 articles.

1. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE

2. Updates in thrombosis in pediatrics: where are we after 20 years?

3. Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007

4. Antithrombotic Therapy in Neonates and Children

5. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure Matching‐Based Pediatric Dose Selection for Drugs with Renal Excretion – Lessons Learned from Pediatric Development of Direct Oral Anticoagulants;Clinical Pharmacology & Therapeutics;2024-08-13

2. Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer;British Journal of Cancer;2024-06-11

3. Anticoagulation of pediatric patients with venous thromboembolism in 2023;Thrombosis Research;2024-03

4. Dabigatran pharmacokinetic-pharmacodynamic in sheep: Informing dose for anticoagulation during cardiopulmonary bypass;Perfusion;2024-01-03

5. Real-world experience with edoxaban for anticoagulation in children at risk for coronary artery thrombosis;Cardiology in the Young;2023-11-03